* Note: Prices are in Million (M) USD.
Description:
Treace Medical Concepts, Inc., an orthopedic medical device company, is dedicated to the design, manufacture, and marketing of biological devices and / or solutions for foot and ankle surgeons in the United States. The company is headquartered in Ponte Vedra Beach, Florida.
These criteria used Company's Cash, EBITDA and Debt balance to determines its fair value:
Cash : $11 M
Debt : $70 M
EBITDA : $-44 M
Net Debt (Debt - Cash): $58 M
Since Ebitda is less than 0, 0 points assigned.
This criteria used industry in which company operates:
Sector: Health Care
Industry: Medical Devices
Based on industry, 3 points assigned.
This criteria used Company's Price To Earning (P/E) Ratio to determines its fair value:
Message: Cannot calculate PE Ratio since EPS is either 0 or negative.
Using default values for calculation.
Forward PE Ratio (using default values): 20.00
Since Forward PE Ratio is between 20 - 25, 2 points assigned.
This criteria used Company's ability to convert Sales into free cash flow to determine fair value:
Average Free Cash Flow: $-29 M
Average Revenue: $122 M
Revenue Converted To Free Cash Flow (%): -24%
Avg Free Cash Flow Growth Per Year (Last 5 Years): -71.21%
Since Free Cash Flow (FCF) to Revenue percentage is non-positive, 0 point assigned.
This criteria used company's growth potential to calculate its fair value:
Latest Revenue (2024-12-31): $209 M
Revenue 4 Years Ago (2020-12-31): $57 M
Last 5 Years Average Revenue Growth: 53%
Since Revenue Growth is greater than 20, 5 points assigned.
This criteria used Company's ability to buy back its own share:
Latest Share Count (2024-12-31): $62 M
Share Count 5 Years Ago (2020-12-31): $51 M
Company is not buying back its own shares, 0 points assigned.
This criteria used Company's dividend payout ratio to determine its fair value:
Message: Cannot calculate payout ratio because EPS is either 0 or negative.
Using default values for calculation.
Based on default values, 1 points assigned.
This criteria used Company's Return On Equity (ROE%) to determine its fair value:
Average ROE: -197%
Since Average ROE is negative, 0 point assigned.
This criteria used Company's current price to its 52 week low price to determines its fair value:
Current Price: $8
52-Week Low: $5
Threshold Price (15% Above 52-Week Low): $5
Since Current price is not within 15% threshold, 0 point assigned.
This criteria used Company's Market Cap to determines its fair value:
Market Capitalization: $348 M
Since Market Cap is less than 10B, 1 point assigned.
% Exposure to Total Portfolio
Based the market cap, we recommend do not exceed 0.5% exposure of Total Portfolio.
Value-Trade has assigned 12 points to above Treace Medical Concepts Inc (TMCI) stock.
Fair Value PE 12, Industry Based PE 18, Growth Based PE 50. Based on these 3 values, average assigned is 26.67.
The fair value of Treace Medical Concepts Inc (TMCI) stock cannot be calculated since EBITDA and EPS are either 0 or negative.
